Stay updated on Efficacy of Port Delivery System in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Port Delivery System in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Efficacy of Port Delivery System in Diabetic Macular Edema Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record now presents details for the Pagoda study of ranibizumab delivery systems for diabetic macular edema, including eligibility, treatment arms, outcomes, and study locations. It also includes record dates, publications, and data-sharing information.SummaryDifference100%

- Check14 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide notice announces NIH updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the main study content with a standard error view. This change renders the study page inaccessible to users attempting to view the Pagoda study details.SummaryDifference19%

Stay in the know with updates to Efficacy of Port Delivery System in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Port Delivery System in Diabetic Macular Edema Clinical Trial page.